SMART bispecific mAb (PDL)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSMART bispecific mAb (PDL)

Drug Alias NameSMART bispecificMAbs (PDL)bispecific antibody technology (PDL)leucine zipper (PDL)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSkin NeoplasmsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPdl Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPdl Biopharma Inc

Active IndicationsN/A

Inactive IndicationsSkin NeoplasmsLymphomaLeukemia

Other Information

ATC CodeN/A